Long-term Immunogenicity After Receipt of JE Vaccine and Antibody Response and Safety to a Booster Dose

NCT02514746 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

561

Enrollment

OTHER

Sponsor class

Conditions

Encephalitis, Japanese

Interventions

BIOLOGICAL: Live Attenuated Japanese Encephalitis SA-14-14-2 Vaccine

Sponsor

PATH

Collaborators

[object Object]